Quick Takeaways
- Redmile Group, LLC filed SCHEDULE 13G/A for Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX).
- Disclosed ownership: 9.9%.
- Date of event: 20 Apr 2026.
Redmile Group, LLC - 20 Apr 2026 SCHEDULE 13G/A Report for Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX)
- Filing Manager
- Redmile Group, LLC
- Reporting Manager
- Redmile Group, LLC
- Symbol
- NRIX
- Shares outstanding
- 108,043,576 shares
- Disclosed Ownership
- 10,696,314 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 24 Apr 2026, 21:28:23 UTC
- Date of event
- 20 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Redmile Group, LLC disclosed 9.9% ownership in Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX) on 20 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 24 Apr 2026, 21:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | 9.9% | 10,696,314 | 0 | 10,696,314 | /s/ Jeremy C. Green | Managing Member | |
| Jeremy C. Green | 9.9% | 10,696,314 | 0 | 10,696,314 | /s/ Jeremy C. Green | Jeremy C. Green | |
| RedCo II Offshore SPV LLC | 5.6% | 5,967,424 | 0 | 5,967,424 | /s/ Jeremy C. Green | Managing Member of Redmile Group, LLC, its manager | |
| RedCo II Master Fund, L.P. | 0% | 0 | 0 | 0 | /s/ Jeremy C. Green | Managing Member of RedCo II (GP), LLC, General Partner of RedCo II Master Fund, L.P. |